STOCK TITAN

Ibex Ltd Financials

IBEX
Trailing 12 months to March 31, 2026
Revenue $626.9M +17.0% YoY
Net Income $47.2M +27.1% YoY
EPS (Diluted) $3.20 +40.4% YoY
Free Cash Flow $32.3M +63.9% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD FYE June

Ibex Ltd (IBEX) reported $626.9M in revenue over the twelve months to Mar 31, 2026, up 17.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IBEX FY2025

Margin expansion and cash generation persist, while aggressive buybacks reshape IBEX’s equity base and liquidity profile.

Gross margin climbed from 28.3% in FY2023 to 30.9% in FY2025 even as revenue first contracted and then recovered, indicating a business improvement beyond simple volume growth. FY2025 operating cash flow of $45.7M exceeded net income of $36.9M, while free cash flow remained positive after $18.4M of capital spending; reported earnings therefore translated into cash without requiring unusually light reinvestment.

The margin shape points to improving delivery economics or revenue mix rather than proven pricing power: operating margin reached 8.4% in FY2025 from 7.7% in FY2023, despite selling, general and administrative expense rising to $108.7M. Profit grew faster than revenue over that span, showing that additional gross profit was partly retained after overhead.

IBEX remains lightly debt-funded, with debt-to-equity at just 0.6% in FY2025, but its balance sheet became less flexible after $78.0M of share buybacks. Equity fell to $134.3M from $165.8M in FY2024, while the current ratio declined to 1.8% from 2.5%; the shift reflects capital returned to shareholders rather than debt accumulation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 64 / 100
Financial Health Score 64/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ibex Ltd's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
67

Ibex Ltd has an operating margin of 8.3%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is up from 7.8% the prior year.

Growth
43

Ibex Ltd's revenue grew 9.8% year-over-year to $558.3M, a solid pace of expansion. This earns a growth score of 43/100.

Leverage
92

Ibex Ltd carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
52

Ibex Ltd's current ratio of 1.82 indicates adequate short-term liquidity, earning a score of 52/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
47

Ibex Ltd has a free cash flow margin of 4.9%, earning a moderate score of 47/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
85

Ibex Ltd earns a strong 27.5% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 85/100. This is up from 20.3% the prior year.

Altman Z-Score Safe
5.23

Ibex Ltd scores 5.23, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Ibex Ltd passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.24x

For every $1 of reported earnings, Ibex Ltd generates $1.24 in operating cash flow ($45.7M OCF vs $36.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
28.53x

Ibex Ltd earns $28.53 in operating income for every $1 of interest expense ($46.6M vs $1.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$558.3M
YoY+9.8%

Ibex Ltd generated $558.3M in revenue in fiscal year 2025. This represents an increase of 9.8% from the prior year.

EBITDA
$63.8M
YoY+8.4%

Ibex Ltd's EBITDA was $63.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.4% from the prior year.

Net Income
$36.9M
YoY+9.5%

Ibex Ltd reported $36.9M in net income in fiscal year 2025. This represents an increase of 9.5% from the prior year.

EPS (Diluted)
$2.36
YoY+28.3%

Ibex Ltd earned $2.36 per diluted share (EPS) in fiscal year 2025. This represents an increase of 28.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$27.3M
YoY+0.9%

Ibex Ltd generated $27.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 0.9% from the prior year.

Cash & Debt
$15.3M
YoY-75.5%

Ibex Ltd held $15.3M in cash against $796K in long-term debt as of fiscal year 2025, with $79.9M of liabilities due within a year.

Shares Outstanding
13M
YoY-20.8%

Ibex Ltd had 13M shares outstanding in fiscal year 2025. This represents a decrease of 20.8% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
30.9%
YoY+1.0pp

Ibex Ltd's gross margin was 30.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.0 percentage points from the prior year.

Operating Margin
8.3%
YoY+0.6pp

Ibex Ltd's operating margin was 8.3% in fiscal year 2025, reflecting core business profitability. This is up 0.6 percentage points from the prior year.

Net Margin
6.6%
YoY0.0pp

Ibex Ltd's net profit margin was 6.6% in fiscal year 2025, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity
27.5%
YoY+7.2pp

Ibex Ltd's ROE was 27.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.2 percentage points from the prior year.

Capital Allocation

Share Buybacks
$78.0M
YoY+261.9%

Ibex Ltd spent $78.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 261.9% from the prior year.

Capital Expenditures
$18.4M
YoY+107.5%

Ibex Ltd invested $18.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 107.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

IBEX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IBEX quarterly income statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Revenue$164.4M+0.1%$164.2M+8.6%$151.2M+2.7%$147.1M+4.5%$140.7M0.0%$140.7M+8.5%$129.7M+4.2%$124.5M
Cost of Revenue$115.6M-0.9%$116.6M+9.4%$106.6M+5.7%$100.9M+5.1%$96.0M-2.8%$98.8M+9.7%$90.0M+5.5%$85.4M
Gross Profit$48.8M+2.5%$47.6M+6.7%$44.6M-3.6%$46.3M+3.5%$44.7M+6.7%$41.9M+5.7%$39.7M+1.3%$39.2M
SG&A Expenses$27.5M-0.3%$27.6M+3.9%$26.5M-10.9%$29.8M+10.0%$27.1M+5.3%$25.7M-1.9%$26.2M+20.9%$21.7M
Operating Income$16.2M+5.7%$15.3M+11.6%$13.7M+11.7%$12.3M-8.0%$13.3M+11.7%$11.9M+31.2%$9.1M-29.3%$12.9M
Interest Expense$249K+0.4%$248K+14.3%$217K-51.6%$448K+10.9%$404K-34.8%$620K+282.7%$162K-7.4%$175K
Income Tax$2.6M-8.2%$2.9M+96.0%$1.5M-34.6%$2.2M-9.7%$2.5M+5.8%$2.4M+18.6%$2.0M-41.6%$3.4M
Net Income$13.3M+9.1%$12.2M+1.5%$12.0M+25.5%$9.6M-8.3%$10.5M+13.0%$9.3M+23.1%$7.5M-23.5%$9.8M
EPS (Diluted)$0.89+7.2%$0.83+1.2%$0.82+24.2%$0.66-9.6%$0.73+28.1%$0.57+32.6%$0.43-21.8%$0.55

Not reported in any period shown, so not listed: R&D Expenses.

IBEX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IBEX quarterly balance sheet
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Total Assets$297.2M+0.5%$295.8M+4.2%$283.9M+3.9%$273.2M-0.6%$274.7M+0.8%$272.5M-11.0%$306.3M+4.2%$293.9M
Current Assets$165.4M+4.4%$158.5M+3.8%$152.8M+4.9%$145.6M-2.0%$148.7M-6.5%$159.0M-15.7%$188.5M+4.8%$180.0M
Cash & Equivalents$15.4M-0.3%$15.5M-31.9%$22.7M+47.8%$15.3M+18.3%$13.0M-35.8%$20.2M-67.6%$62.3M-0.7%$62.7M
Accounts Receivable$129.2M-1.0%$130.5M+12.5%$116.0M-0.9%$117.1M-2.4%$120.0M-0.5%$120.6M+13.7%$106.0M+7.8%$98.4M
Goodwill$11.8M0.0%$11.8M0.0%$11.8M0.0%$11.8M0.0%$11.8M0.0%$11.8M0.0%$11.8M0.0%$11.8M
Total Liabilities$136.5M-3.4%$141.3M+0.7%$140.2M+1.0%$138.9M-7.7%$150.6M-8.0%$163.6M+21.0%$135.2M+5.5%$128.1M
Current Liabilities$84.8M-2.0%$86.5M+3.0%$84.0M+5.1%$79.9M-10.2%$89.0M-19.6%$110.6M+42.3%$77.8M+9.5%$71.0M
Long-Term Debt$572K-3.7%$594K-18.2%$726K-8.8%$796K+8.3%$735K+5.8%$695K-13.3%$802K-7.5%$867K
Total Equity$160.8M+4.1%$154.5M+7.6%$143.6M+6.9%$134.3M+8.2%$124.2M+14.0%$108.9M-36.3%$171.1M+3.2%$165.8M
Retained Earnings$63.3M+26.7%$50.0M+32.3%$37.8M+46.8%$25.7M+59.4%$16.1M+184.4%$5.7M+258.0%-$3.6M+67.7%-$11.1M

Not reported in any period shown, so not listed: Inventory.

IBEX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

IBEX quarterly cash flow statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Operating Cash Flow$11.9M+78.6%$6.6M-57.6%$15.7M-43.9%$27.9M+216.5%$8.8M+673.7%$1.1M-85.3%$7.8M-55.4%$17.4M
Capital Expenditures$5.3M-55.1%$11.7M+53.6%$7.6M+48.1%$5.2M-2.1%$5.3M+21.9%$4.3M+19.0%$3.6M+63.5%$2.2M
Free Cash Flow$6.6M+229.5%-$5.1M-163.4%$8.0M-64.7%$22.8M+539.7%$3.6M+212.1%-$3.2M-176.9%$4.1M-72.8%$15.2M
Investing Cash Flow-$5.3M+55.1%-$11.7M-53.6%-$7.6M-48.1%-$5.2M+2.1%-$5.3M-21.9%-$4.3M-19.0%-$3.6M-63.5%-$2.2M
Financing Cash Flow-$6.7M-210.0%-$2.1M-232.0%-$647K+96.8%-$20.2M-85.2%-$10.9M+71.9%-$38.9M-746.4%-$4.6M-45.9%-$3.1M
Share Buybacks$4.6M+64.4%$2.8M+0.7%$2.8M+73.7%$1.6M-93.6%$25.1M-46.2%$46.6M+868.6%$4.8M+60.0%$3.0M

Not reported in any period shown, so not listed: Dividends Paid.

IBEX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

IBEX quarterly financial ratios
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Gross Margin29.7%+0.7pp29.0%-0.5pp29.5%-1.9pp31.4%-0.3pp31.8%+2.0pp29.8%-0.8pp30.6%-0.9pp31.4%
Operating Margin9.8%+0.5pp9.3%+0.3pp9.1%+0.7pp8.3%-1.1pp9.5%+1.0pp8.5%+1.5pp7.0%-3.3pp10.3%
Net Margin8.1%+0.7pp7.4%-0.5pp8.0%+1.4pp6.5%-0.9pp7.4%+0.8pp6.6%+0.8pp5.8%-2.1pp7.9%
Return on Equity8.3%+0.4pp7.9%-0.5pp8.4%+1.2pp7.1%-1.3pp8.4%-0.1pp8.5%+4.1pp4.4%-1.5pp5.9%
Return on Assets4.5%+0.3pp4.1%-0.1pp4.2%+0.7pp3.5%-0.3pp3.8%+0.4pp3.4%+0.9pp2.5%-0.9pp3.4%
Current Ratio1.95+0.1x1.830.0x1.820.0x1.82+0.2x1.67+0.2x1.44-1.0x2.42-0.1x2.53
Debt-to-Equity0.000.0x0.000.0x0.010.0x0.010.0x0.010.0x0.010.0x0.000.0x0.01
FCF Margin4.0%+7.1pp-3.1%-8.4pp5.3%-10.2pp15.5%+13.0pp2.5%+4.8pp-2.3%-5.4pp3.2%-9.0pp12.2%

Similar Companies

Frequently Asked Questions

What is Ibex Ltd's annual revenue?

Ibex Ltd (IBEX) reported $558.3M in total revenue for fiscal year 2025. This represents a 9.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ibex Ltd's revenue growing?

Ibex Ltd (IBEX) revenue grew by 9.8% year-over-year, from $508.6M to $558.3M in fiscal year 2025.

Is Ibex Ltd profitable?

Yes, Ibex Ltd (IBEX) reported a net income of $36.9M in fiscal year 2025, with a net profit margin of 6.6%.

Ibex Ltd (IBEX) reported diluted earnings per share of $2.36 for fiscal year 2025. This represents a 28.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ibex Ltd (IBEX) had EBITDA of $63.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Ibex Ltd (IBEX) had $15.3M in cash and equivalents against $796K in long-term debt.

Ibex Ltd (IBEX) had a gross margin of 30.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ibex Ltd (IBEX) had an operating margin of 8.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ibex Ltd (IBEX) had a net profit margin of 6.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ibex Ltd (IBEX) has a return on equity of 27.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ibex Ltd (IBEX) generated $27.3M in free cash flow during fiscal year 2025. This represents a 0.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ibex Ltd (IBEX) generated $45.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ibex Ltd (IBEX) had $273.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Ibex Ltd (IBEX) invested $18.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Ibex Ltd (IBEX) spent $78.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Ibex Ltd (IBEX) had 13M shares outstanding as of fiscal year 2025.

Ibex Ltd (IBEX) had a current ratio of 1.82 as of fiscal year 2025, which is generally considered healthy.

Ibex Ltd (IBEX) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ibex Ltd (IBEX) had a return on assets of 13.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Ibex Ltd (IBEX) has an Altman Z-Score of 5.23, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ibex Ltd (IBEX) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ibex Ltd (IBEX) has an earnings quality ratio of 1.24x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ibex Ltd (IBEX) has an interest coverage ratio of 28.53x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ibex Ltd (IBEX) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top